Respiratory Disease Testing Market Forecasted to Reach USD 3,143.3 Mn by 2022

Respiratory diseases are those that affect organs and tissues within the respiratory system. These diseases could affect various parts within the respiratory system, including nerves and muscles that enable breathing, trachea, alveoli, trachea, and bronchi. Respiratory disease testing is conducted using a variety of equipment that carries the capability to detect pulmonary abnormalities. The respiratory disease testing market is witnessing amplified demand owing to the increased prevalence of respiratory diseases such as pneumonia, chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis.

At the same time, an expansion in the geriatric population base will drive up demand in the global respiratory disease testing market. According to recent market research reports, the growth in this market could be hampered to some extent by the sluggish adoption rate of portable spirometers and digital radiography. The global market for respiratory disease testing stood at US$ 2,326.5 million as of 2013, and is expected to expand at a moderate CAGR of 3.4% between 2014 and 2022 to approximate US$3,143.3 million by 2022.

Obtain Report Details @ https://www.transparencymarketresearch.com/respiratory-disease-testing.html

Imaging Tests Occupy Largest Share in Global Respiratory Disease Testing Market

The global respiratory disease testing market can be sectioned into small segments based on the type of tests conducted. With this, the key segments are: Imaging test, peak flow test, spirometry, lung volume test, blood gas test, and others. Imaging tests – such as X-rays – are seen to be the most widely deployed test type, making this segment the largest in the global respiratory disease testing market. Imaging tests are prescribed for first-line diagnosis of respiratory diseases, making them much more common than the other types of tests.

The prospects of the spirometry test segment look positive, as this segment is expected to report the highest CAGR over the next few years. The growth of the spirometry test segment can be attributed to their rapid, effective, and accurate diagnostic abilities. Physicians increasingly recommend this test for lung function testing.

Request For Sample of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1288

Demand for Respiratory Disease Testing Seen to be Highest from Hospitals

Segmented on the basis of end users, the global respiratory disease testing market is composed of physician offices, hospitals, and clinical laboratories. According to data collected in 2013, the hospitals segment was the largest end-user within the respiratory disease testing market. Hospitals typically carry a large array of in-house respiratory diagnostic instruments—both imaging and lung function—to test patients. Because in-house diagnostic infrastructure offers more convenience and revenue to hospitals, they continue to invest in or upgrade to the latest equipment.

All of these factors contribute in making the hospitals segment the largest in the global respiratory disease testing market.

North America Leads Global Respiratory Disease Testing Market; APAC to Show Strongest Growth in Near Future

North America occupied the largest share within the global market for respiratory disease testing in 2013, market reports show. The conditions in the North America market are conducive to the growth of the respiratory disease testing market. Statistics from the CDC show that the U.S. had nearly 18.7 million adults suffering from asthma. Moreover, the American Lung Association puts COPD at the third spot among the top leading causes of death in the U.S. Besides the sheer prevalence of respiratory diseases, the North America respiratory disease testing market’s other growth driver is seen to be the popularity of compact, portable devices from end users.

Request For Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1288

Although North America is the leader in the respiratory disease testing market, the region will be outpaced by the Asia Pacific market in terms of growth rate. The latter is driven by rapidly emerging economies where the demand for respiratory disease testing is soaring.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.